Jagsonpal Pharma has investments by Mukul Agrawal (₹28 Cr), Lincoln Coelho (₹19 Cr) & Sanjay Dangi (Authum) (₹23 Cr). M-Cap is ₹1600 Cr. Promoters hold 68%. Co is Debt-Free. RoCE is 18%. It has a portfolio of drugs focusing on Gynecology & Orthopedic with many leading brands
![[IMG]](https://pbs.twimg.com/media/Gbya0zPasAA8sOH?format=png&name=small)
![[IMG]](https://pbs.twimg.com/media/Gbya0zPa4AAjf1a?format=png&name=900x900)
| Subscribe To Our Free Newsletter |
